Herbst Group’s Idexx Laboratories IDXX Stock Holding History

Herbst Group’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-900	Closed	-$438K	–	64
2024 Q2	$438K	Hold	900	–	–	0.27%	58
2024 Q1	$486K	Buy	+900	New	+$492K	0.3%	56

Other funds holding IDXX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Herbst Group's IDXX Position: Q3 2024 in Review

Herbst Group sold out of Idexx Laboratories (IDXX) in Q3 2024, closing a stake of 900 shares — an estimated $438K sold.

Herbst Group first reported a position in IDXX in Q1 2024 and held it in 2 quarters. The position peaked at $486K in Q1 2024. 1,116 funds tracked by Wall St. Rank hold IDXX as of Q3 2024.

Herbst Group reported no remaining Idexx Laboratories position as of Q3 2024 after selling out during the quarter.
Herbst Group sold 900 Idexx Laboratories shares in Q3 2024, an estimated $438K.
Herbst Group first reported a position in Idexx Laboratories in Q1 2024 and held it in 2 quarters.
Herbst Group's Idexx Laboratories position peaked at $486K in Q1 2024.
1,116 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2024.

Based on Herbst Group's 13F filing for Q3 2024, filed 7 Oct 2024.